As the inflammatory process that ensues after a stroke destabilizes the BBB and contributes to neuro-axonal damage, resulting in the release of neurofilaments and glial markers into the blood [51,52,53], we assessed serum NF-L and GFAP levels (Figure 5d–e). The gene discussed is GFAP; the disease is stroke disorder.